Krajina: Spojené štáty
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM)
Northwind Pharmaceuticals
ORAL
PRESCRIPTION DRUG
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Ibuprofen tablets are indicated for relief of mild to moderate pain. Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. Controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. CONTRAINDICATIONS Ibuprofen tablets are contraindicated in patients with known hypersensitivity to Ibuprofen. Ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have
800 mg (white to off-white, capsule shaped, biconvex, film-coated tablets debossed with ‘123’ on one side and plain on other side) NDC: 51655-275-54 15 Bottles NDC: 51655-275-20 20 Bottles NDC: 51655-275-21 21 Bottles NDC: 51655-275-25 60 Bottles NDC: 51655-275-26 90 Botlles
Abbreviated New Drug Application
Northwind Pharmaceuticals ---------- IBUPROFEN TABLETS 400 MG - 600 MG- 800 MG MEDGUIDE Revised: 1/2023 Document Id: d9f2ae7d-6c41-6429-e053-2a95a90ab8dc 34391-3 Set id: c20f1f4d-59b3-6bbe-e053-2a95a90abaf1 Version: 2 Effective Time: 20230101 Northwind Pharmaceuticals Prečítajte si celý dokument
IBUPROFEN- IBUPROFEN TABLET, FILM COATED NORTHWIND PHARMACEUTICALS ---------- IBUPROFEN 800 MG TABLETS IBUPROFEN TABLETS 400 MG - 600 MG- 800 MG MEDGUIDE 800 mg (white to off-white, capsule shaped, biconvex, film-coated tablets debossed with ‘123’ on one side and plain on other side) NDC: 51655-275-54 15 Bottles NDC: 51655-275-20 20 Bottles NDC: 51655-275-21 21 Bottles NDC: 51655-275-25 60 Bottles NDC: 51655-275-26 90 Botlles 800 MG 20 COUNT LABEL NDC: 51655-275-20 IBUPROFEN ibuprofen tablet, film coated PRODUCT INFORMATION PRODUCT TYPE HUMAN PRESCRIPTION DRUG ITEM CODE (SOURCE) NDC:51655-275(NDC:49483- 604) ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) IBUPROFEN 800 mg INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POLYVINYL ALCOHOL (UNII: 532B59J990) STARCH, PREGELATINIZED CORN (UNII: O8232NY3SJ) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) PRODUCT CHARACTERISTICS COLOR white SCORE no score SHAPE CAPSULE SIZE 19mm FLAVOR IMPRINT CODE 123 Northwind Pharmaceuticals CONTAINS PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:51655- 275-20 20 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 07/09/2021 2 NDC:51655- 275-21 21 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 10/29/2020 3 NDC:51655- 275-25 60 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 02/17/2021 4 NDC:51655- 275-26 90 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 06/16/2020 5 NDC:51655- 275-54 15 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 09/21/2020 MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE ANDA ANDA090796 06/16/2020 LABELER - Northwind Pharmac Prečítajte si celý dokument